Български
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

The INITIATE Study: Initiating Nicotine Dependence Treatment for Smokers Admitted to Emergency Departments

Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
Линкът е запазен в клипборда
СъстояниеВсе още не набира
Спонсори
Ottawa Heart Institute Research Corporation
Сътрудници
Canadian Institutes of Health Research (CIHR)

Ключови думи

Резюме

The INITIATE Study is a randomized controlled trial that is testing an intervention designed to increase long-term abstinence among tobacco smokers seen in emergency departments (ED). The intervention includes a behavioural incentive and tailored follow-up support on long-term smoking abstinence, health, healthcare utilization, and cost. Tobacco-related illnesses cost the healthcare system millions each year. Quitting smoking improves smoking-related outcomes, like the onset or management of heart disease, stroke, lung diseases, and several cancers. There are approximately 16 million visits to Canadian EDs each year; an estimated 3-4 million of these involve smokers. Effective quit smoking interventions exist, but are underutilized. Few hospital EDs in Canada offer tobacco-use interventions. In order for ED staff to offer quit smoking support, interventions need to be simple given the realities of the ED environment. Considering that stopping smoking improves health outcomes, that tobacco-use is an important cause of preventable ED use, and the volume of smokers, Canadian EDs are a missed opportunity in the initiation of quit smoking support. Our intervention has been designed to optimize uptake and smoking abstinence by including the most effective evidence-based behavioural and drug-related approaches, removing specific barriers and challenges that smokers face when trying to quit (e.g., affordability, low confidence and motivation), while packaging the intervention in a quick-to-initiate manner, making it ideal for fast-paced, complex ED environments.

Дати

Последна проверка: 04/30/2020
Първо изпратено: 10/06/2019
Очаквано записване подадено: 11/12/2019
Първо публикувано: 11/13/2019
Изпратена последна актуализация: 05/07/2020
Последна актуализация публикувана: 05/10/2020
Действителна начална дата на проучването: 07/31/2020
Приблизителна дата на първично завършване: 06/30/2021
Очаквана дата на завършване на проучването: 10/31/2022

Състояние или заболяване

Nicotine Dependence, Cigarettes
Nicotine Withdrawal

Интервенция / лечение

Behavioral: Quit Card Intervention (QCI)

Фаза

-

Групи за ръце

ArmИнтервенция / лечение
Experimental: Quit Card Intervention (QCI)
Study intervention group.
Behavioral: Quit Card Intervention (QCI)
The intervention is comprised of a behavioural incentive in the form of a gift card as well as tailored smoking cessation counseling. Eligible consenting smokers randomized to the QCI group will receive: a "Quit Card" (a gift card worth $300 that can be used to buy nicotine replacement therapies at any pharmacy); self-help information; and, enrollment in six months of telephone follow-up support tailored by treatment goal with a Nicotine Addiction Treatment Specialist.
No Intervention: Usual Care (UC)
Study control group.

Критерии за допустимост

Възрасти, отговарящи на условията за проучване 18 Years Да се 18 Years
Полове, допустими за проучванеAll
Приема здрави доброволциДа
Критерии

Inclusion Criteria:

- Current daily smoker (smokes ≥ 5 cigarettes per day);

- ≥ 18 years of age (the age of majority in Ontario);

- Assigned a CTAS level of 2-5 (emergent to non-urgent);

- Able to read and understand English or French;

- Resides in Ontario and eligible for Ontario Health Insurance Plan (to permit linkage with administrative data housed at the Institute for Clinical Evaluative Sciences [ICES]);

- Available and willing to participate in follow-up assessments over the next 24 months;

- Has access to a telephone or computer;

- Able to provide informed consent

Exclusion Criteria:

- Currently participating in this or another smoking cessation study;

- Assigned a CTAS level of 1 (resuscitation - the most seriously ill patients with highest likelihood of hospital admission) or in psychiatric emergency unit;

- Pregnant, planning to become pregnant over the next 2 years, or breastfeeding;

- Has morbid illness which will prevent completion of 26-week follow-up (e.g., receiving palliative care);

- In the opinion of the ED physician, manifests acute physical and/or psychiatric illness or has cognitive impairment that would preclude participation in/benefit from the intervention.

Резултат

Първични изходни мерки

1. Smoking Abstinence [26 weeks (6 months) after study enrollment]

Smoking abstinence at 26 weeks, biochemically verified using an expired air carbon monoxide (CO) test

Вторични изходни мерки

1. Prolonged Abstinence [4, 26, 52 and 104 weeks after study enrollment]

Prolonged (since last time point) smoking abstinence, at 4, 26, 52 and 104 weeks

2. Point Prevalence Abstinence [4, 52 and 104 weeks after study enrollment]

Point prevalence smoking abstinence, at 4, 52 and 104 weeks

3. Smoking Reduction [4, 26, 52 and 104 weeks after study enrollment]

Smoking reduction (i.e., change in number of daily cigarettes), at 4, 26, 52 and 104 weeks

4. Number of Quit Attempts [4, 26, 52 and 104 weeks after study enrollment]

Number of quit attempts since study entry, at 4, 26, 52 and 104 weeks

5. Cessation Medication and/or E-cigarette Use [4, 26, 52 and 104 weeks after study enrollment]

Use of smoking cessation medication and/or e-cigarette, at 4, 26, 52 and 104 weeks

6. Use of Behavioural Supports [4, 26, 52 and 104 weeks after study enrollment]

Use of behavioural supports (e.g., counseling, quit lines), at 4, 26, 52 and 104 weeks

7. Health-Related Quality of Life [52 and 104 weeks after study enrollment]

Health-related quality of life (HR-QoL), at 52 and 104 weeks. This will be measured using the 36-Item Short Form Health Survey (SF-36), where each item is scored so that the lowest and highest possible scores are 0 and 100 respectively, and a high score outlines a more favorable state of health.

8. Health Services Outcomes - ED visits [4, 26, 52 and 104 weeks after study enrollment]

Number of all-cause and smoking-related (e.g., vascular, respiratory, cancer-related) visits to ED at 4, 26, 52 and 104 weeks

9. Health Services Outcomes - Hospital Admissions [4, 26, 52 and 104 weeks after study enrollment]

Number of all-cause and smoking-related (e.g., vascular, respiratory, cancer-related) admissions to hospital at 4, 26, 52 and 104 weeks

10. Health Services Outcomes - Deaths [4, 26, 52 and 104 weeks after study enrollment]

Number of all-cause and smoking-related (e.g., vascular, respiratory, cancer-related) deaths at 4, 26, 52 and 104 weeks

11. Cost-Effectiveness Ratios [52 and 104 weeks after study enrollment]

Cost-effectiveness ratios related to health services at 52 and 104 weeks

Присъединете се към нашата
страница във facebook

Най-пълната база данни за лечебни билки, подкрепена от науката

  • Работи на 55 езика
  • Билкови лекове, подкрепени от науката
  • Разпознаване на билки по изображение
  • Интерактивна GPS карта - маркирайте билките на място (очаквайте скоро)
  • Прочетете научни публикации, свързани с вашето търсене
  • Търсете лечебни билки по техните ефекти
  • Организирайте вашите интереси и бъдете в крак с научните статии, клиничните изследвания и патентите

Въведете симптом или болест и прочетете за билките, които биха могли да помогнат, напишете билка и вижте болестите и симптомите, срещу които се използва.
* Цялата информация се базира на публикувани научни изследвания

Google Play badgeApp Store badge